相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)
Paolo Spagnolo et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Pharmacological treatments for SSc-ILD: Systematic review and critical appraisal of the evidence
Madelon C. Vonk et al.
AUTOIMMUNITY REVIEWS (2021)
Efficacy and safety of rituximab on lung and skin involvement in systemic sclerosis: a systematic review and metaanalysis
Sasimon Borrirukwisitsak et al.
CLINICAL RHEUMATOLOGY (2021)
Is rituximab effective for systemic sclerosis? A systematic review and meta-analysis
Marina Maria Vieira de Figueiredo Caldas et al.
ADVANCES IN RHEUMATOLOGY (2021)
Treatment for systemic sclerosis-associated interstitial lung disease
David Roofeh et al.
CURRENT OPINION IN RHEUMATOLOGY (2021)
New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine
Alain Lescoat et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
Methods for depicting overlap in overviews of systematic reviews: An introduction to static tabular and graphical displays
Konstantinos I. Bougioukas et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2021)
Current issues in rheumatoid arthritis-associated interstitial lung disease
Clive Kelly et al.
Lancet Rheumatology (2021)
The safety of nintedanib for the treatment of interstitial lung disease: A systematic review and meta-analysis of randomized controlled trials
Chao-Hsien Chen et al.
PLOS ONE (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review
Esther F. Vicente-Rabaneda et al.
AUTOIMMUNITY REVIEWS (2021)
Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
Xinyu Ma et al.
CLINICAL RHEUMATOLOGY (2021)
Safety and efficacy of rituximab in connective tissue disease-associated interstitial lung disease: A systematic review and meta-analysis
Nan-shu Xing et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Treatment of fibrotic interstitial lung disease: current approaches and future directions
Kerri A. Johannson et al.
LANCET (2021)
An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years
Corrado Campochiaro et al.
ARTHRITIS RESEARCH & THERAPY (2021)
Rituximab in the treatment of systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
Rudra P. Goswami et al.
RHEUMATOLOGY (2021)
Comparative efficacy and safety of immunosuppressive therapies for systemic sclerosis related interstitial lung disease: A Bayesian network analysis
Ji-Na Zheng et al.
MODERN RHEUMATOLOGY (2020)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
Gian Luca Erre et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment
Niranjan Jeganathan et al.
LUNG (2020)
Spectrum of Fibrotic Lung Diseases
Marlies Wijsenbeek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
Anna-Maria Hoffmann-Vold et al.
LANCET RHEUMATOLOGY (2020)
Ongoing clinical trials and treatment options for patients with systemic sclerosis-associated interstitial lung disease
Dinesh Khanna et al.
RHEUMATOLOGY (2019)
Definition of a systematic review used in overviews of systematic reviews, meta-epidemiological studies and textbooks
Marina Krnic Martinic et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis
Thomas Barba et al.
AUTOIMMUNITY REVIEWS (2019)
Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases
Isabel Mira-Avendano et al.
MAYO CLINIC PROCEEDINGS (2019)
A decision tool to help researchers make decisions about including systematic reviews in overviews of reviews of healthcare interventions
Michelle Pollock et al.
SYSTEMATIC REVIEWS (2019)
Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms
Konstantinos I. Bougioukas et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
Treatment Algorithms for Systemic Sclerosis According to Experts
Andreu Fernandez-Codina et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley J. Shea et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
Beverley J. Shea et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Risk of bias in overviews of reviews: a scoping review of methodological guidance and four-item checklist
Madeleine Ballard et al.
RESEARCH SYNTHESIS METHODS (2017)
Selecting and implementing overview methods: implications from five exemplar overviews
Alex Pollock et al.
SYSTEMATIC REVIEWS (2017)
Interventions to control myopia progression in children: protocol for an overview of systematic reviews and meta-analyses
Efthymia Prousali et al.
SYSTEMATIC REVIEWS (2017)
An algorithm was developed to assign GRADE levels of evidence to comparisons within systematic reviews
Alex Pollock et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Rayyan-a web and mobile app for systematic reviews
Mourad Ouzzani et al.
SYSTEMATIC REVIEWS (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review
Yongpeng Ge et al.
CLINICAL RHEUMATOLOGY (2015)
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
Lazaros Belbasis et al.
LANCET NEUROLOGY (2015)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K. Tsilidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K. Tsilidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach
Edoardo Aromataris et al.
INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)
Systematic review finds overlapping reviews were not mentioned in every other overview
Dawid Pieper et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2014)
KINASE SELECTIVITY PROFILES OF NINTEDANIB AND IMATINIB
R. Rajagopalan et al.
THORAX (2014)
Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials
Evropi Theodoratou et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Clarifications on the application and interpretation of the test for excess significance and its extensions
John P. A. Ioannidis
JOURNAL OF MATHEMATICAL PSYCHOLOGY (2013)
An optimal search filter for retrieving systematic reviews and meta-analyses
Edwin Lee et al.
BMC MEDICAL RESEARCH METHODOLOGY (2012)
GRADE guidelines: 3. Rating the quality of evidence
Howard Balshem et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses
John P. A. Ioannidis
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
A re-evaluation of random-effects meta-analysis
Julian P. T. Higgins et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY (2009)
Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified
Julian P. T. Higgins
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
How quickly do systematic reviews go out of date? A survival analysis
Kaveh G. Shojania et al.
ANNALS OF INTERNAL MEDICINE (2007)
Scleroderma treatment differs between experts and general rheumatologists
JE Pope et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Optimal search strategies for retrieving systematic reviews from Medline: analytical survey
VM Montori et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
分享论文
